Impact of Initial FDG-PET/CT and Serum-Free Light Chain on Transformation of Conventionally Defined Solitary Plasmacytoma to Multiple Myeloma
Guillemette Fouquet(Centre Hospitalier Universitaire de Lille), Xavier Leleu(Inserm), Thierry Façon(Université de Lille), Sarah Bonnet(Hôpital Saint Eloi), David Beauvais(Hôpital Claude Huriez), Charles Herbaux(Centre Hospitalier Universitaire de Lille), D. Huglo(Centre Hospitalier Universitaire de Lille), Mathieu Wémeau(Inserm), Stéphanie Guidez(Inserm), Louis Terriou(Centre Hospitalier Universitaire de Lille), Valérie Coiteux(Lille’s Cardiology Hospital), Margaret Macro(Hôpital Cochin), Zoé Van de Wyngaert(Centre Hospitalier Universitaire de Lille), Céline Berthon(Université Paris-Sud), Olivier Decaux(Hôpital Pontchaillou), Bénédicte Hivert(Hôpital Saint-Vincent-de-Paul), Salim M. Adib(Hôpital Claude Huriez), Hélène Demarquette(Ikerbasque)
Cited by 74
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
|Journal of Neurology Neurosurgery & Psychiatry|1992|1.8k
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
|Nature Communications|2014|906
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719